Summary
52 / 100 · Bulios Score
What speaks for it
- Revenue grew by 264% a year over the last 3 years.
- It earns 22 USD a year on every 100 USD of invested capital.
- Out of every 100 USD of revenue, 13 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 264% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellOver the last 12 months it made a loss of $21.7M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 58.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 7.55%
You receive $1.91 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 7
- Hold 10
- Sell 0
No analyst has published a price target.
41% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.